Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$12.15 - $35.28 $87,723 - $254,721
-7,220 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$30.49 - $48.49 $259,927 - $413,377
-8,525 Reduced 54.14%
7,220 $246,000
Q3 2021

Oct 29, 2021

SELL
$41.66 - $52.52 $1.72 Million - $2.17 Million
-41,360 Reduced 72.43%
15,745 $760,000
Q2 2021

Jul 26, 2021

BUY
$36.62 - $51.69 $1.87 Million - $2.64 Million
51,114 Added 853.18%
57,105 $2.58 Million
Q1 2021

Apr 27, 2021

BUY
$41.56 - $59.88 $48,375 - $69,700
1,164 Added 24.11%
5,991 $289,000
Q4 2020

Jan 25, 2021

BUY
$36.08 - $56.47 $174,158 - $272,580
4,827 New
4,827 $260,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.7B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.